GLAXOSMITHKLINE PLC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-27 06:01 am Unchanged |
2021-08-16 | 13G | Fulcrum Therapeutics, Inc. FULC |
GLAXOSMITHKLINE PLC | 1,785,714 4.500% |
0 (Unchanged) |
Filing |